Company Description

eXoZymes, Inc. operates as a synthetic biochemical company in the United States.

The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.

Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.

The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025.

The company was founded in 2014 and is headquartered in Monrovia, California.

eXoZymes, Inc.

Country	United States
Founded	2014
Industry	Biotechnology
Sector	Healthcare
Employees	29
CEO	Michael Heltzen

Contact Details

Address: 750 Royal Oaks Drive, Suite 106 Monrovia, California 91016 United States
Phone	626 415 1488
Website	invizyne.com

Stock Details

Ticker Symbol	EXOZ
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0002010788
ISIN Number	US4618741098

Key Executives

Name	Position
Michael Heltzen	Chief Executive Officer
Mohammad Hayat J.D.	Co-Founder, Chairman of the Board and President
Dr. Tyler Korman Ph.D.	Co-Founder and Vice President of Research
Dr. Paul Opgenorth Ph.D.	Co-Founder and Vice President of Development
James U. Bowie Ph.D.	Founder and Independent Director
Fouad Nawaz	Vice President of Finance
Lasse H. Gorlitz	Vice President of Communications
Michael Burns	Executive Vice President of Energy Transition
Dr. Zachary Karl Ph.D.	Vice President and Head of Business Development